Kalkine has a fully transformed New Avatar.
Last update at 2025-06-06T06:58:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks
Mon 24 Mar 25, 07:05 PM3 High Growth Tech Stocks in Australia
Thu 20 Feb 25, 04:01 AMHigh Growth Tech Stocks in Australia Featuring Infomedia and Two Others
Thu 16 Jan 25, 04:05 AMPro Medicus' (ASX:PME) five-year earnings growth trails the 60% YoY shareholder returns
Tue 07 Jan 25, 08:18 PMHigh Growth Tech Stocks To Watch In December 2024
Wed 18 Dec 24, 04:02 AMWe Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Tue 10 Dec 24, 10:55 PMExploring Infomedia And 2 Promising High Growth Tech Stocks In Australia
Tue 19 Nov 24, 04:05 AMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | 86.13M | 63.08M | 42.87M | 30.02M | 26.12M |
Minority interest | - | - | - | - | - |
Net income | 60.65M | 44.44M | 30.85M | 23.08M | 23.08M |
Selling general administrative | 24.07M | 15.40M | 13.53M | 12.85M | 12.13M |
Selling and marketing expenses | 2.52M | 1.95M | 0.32M | 1.49M | 1.57M |
Gross profit | 124.24M | 92.94M | 67.35M | 56.42M | 48.67M |
Reconciled depreciation | 7.93M | 7.32M | 7.20M | 7.68M | 6.08M |
Ebit | 83.76M | 62.33M | 42.33M | 30.02M | 25.44M |
Ebitda | 91.69M | 69.64M | 49.53M | 37.71M | 31.52M |
Depreciation and amortization | 7.93M | 7.32M | 7.20M | 7.68M | 6.08M |
Non operating income net other | - | - | - | - | - |
Operating income | 84.08M | 61.31M | 42.63M | 30.07M | 25.44M |
Other operating expenses | 40.12M | 30.10M | 24.21M | 26.26M | 24.64M |
Interest expense | 0.39M | 0.65M | 0.54M | 0.00500M | 0.68M |
Tax provision | 25.48M | 18.64M | 12.02M | 6.94M | 7.00M |
Interest income | 2.43M | 0.65M | 0.18M | 0.17M | 0.24M |
Net interest income | 2.43M | 0.65M | 0.18M | 0.17M | 0.24M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 25.48M | 18.64M | 12.02M | 6.94M | 7.00M |
Total revenue | 124.79M | 93.40M | 67.84M | 56.78M | 50.08M |
Total operating expenses | 40.48M | 30.61M | 25.01M | 26.40M | 23.23M |
Cost of revenue | 0.54M | 0.47M | 0.49M | 0.35M | 1.41M |
Total other income expense net | -0.06600M | 0.10M | 0.36M | -0.17700M | 0.68M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 60.65M | 44.44M | 30.85M | 23.08M | 19.12M |
Net income applicable to common shares | 60.65M | 44.44M | 30.85M | 23.08M | 19.12M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
Total assets | 257.43M | 202.13M | 157.05M | 125.57M | 95.64M |
Intangible assets | 20.07M | 21.35M | 22.29M | 20.01M | 18.84M |
Earning assets | - | - | - | - | - |
Other current assets | 1.89M | 0.78M | 0.45M | 1.57M | 1.03M |
Total liab | 69.70M | 63.36M | 55.32M | 43.89M | 35.46M |
Total stockholder equity | 187.73M | 138.78M | 101.73M | 81.68M | 60.18M |
Deferred long term liab | - | 2.36M | 1.47M | 1.35M | 0.76M |
Other current liab | 15.21M | 16.56M | 14.48M | 7.29M | 4.13M |
Common stock | 23.65M | 1.96M | 1.96M | 1.96M | 1.96M |
Capital stock | 23.65M | 1.96M | 1.96M | 1.96M | 1.96M |
Retained earnings | 173.36M | 127.12M | 92.58M | 66.92M | 49.62M |
Other liab | - | 31.31M | 26.78M | 24.23M | 20.99M |
Good will | - | - | - | - | - |
Other assets | 0.00000M | 12.45M | 47.19M | 43.03M | 40.53M |
Cash | 60.06M | 91.25M | 63.66M | 42.04M | 43.41M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 34.56M | 30.85M | 26.86M | 17.62M | 12.72M |
Current deferred revenue | 17.05M | 12.60M | 10.13M | 8.89M | 7.22M |
Net debt | -57.99300M | -89.39700M | -61.37700M | -39.42100M | -41.13700M |
Short term debt | 0.55M | 0.65M | 0.60M | 0.57M | 0.52M |
Short long term debt | - | - | - | - | - |
Short long term debt total | 2.07M | 1.85M | 2.28M | 2.62M | 2.28M |
Other stockholder equity | - | -129.07500M | -94.53500M | -68.88400M | -51.58200M |
Property plant equipment | - | 2.19M | 2.60M | 3.01M | 2.85M |
Total current assets | 206.56M | 163.79M | 119.82M | 87.57M | 61.48M |
Long term investments | 7.34M | - | - | - | - |
Net tangible assets | - | 117.43M | 79.44M | 61.67M | 41.34M |
Short term investments | 95.36M | 30.25M | 26.90M | 19.78M | 19.78M |
Net receivables | 49.20M | 39.88M | 27.44M | 22.84M | 13.84M |
Long term debt | - | - | - | - | - |
Inventory | 0.05M | 0.06M | 0.08M | 0.03M | 0.04M |
Accounts payable | 1.74M | 1.03M | 1.64M | 0.87M | 0.83M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -9.27700M | 9.70M | 7.20M | 12.80M | 8.60M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | 1.96M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 0.04M | 2.60M | 1.47M | 1.39M | 0.99M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 50.86M | 38.34M | 37.23M | 38.01M | 34.16M |
Capital lease obligations | 2.07M | 1.85M | 2.28M | 2.62M | 2.28M |
Long term debt total | - | 1.20M | 1.68M | 2.04M | 1.75M |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Investments | -7.55700M | -8.53300M | -19.70400M | -7.69900M | -7.30500M |
Change to liabilities | 7.14M | 8.10M | 4.16M | -1.32400M | 7.29M |
Total cashflows from investing activities | -7.55700M | -16.90700M | -27.21700M | -7.69900M | -7.30500M |
Net borrowings | -0.57400M | -0.50900M | -0.50100M | -0.55700M | -0.55700M |
Total cash from financing activities | -27.52700M | -23.31400M | -14.04900M | -12.31500M | -9.84300M |
Change to operating activities | 0.27M | 0.35M | 0.26M | -0.12900M | 0.10M |
Net income | 60.65M | 44.44M | 30.85M | 23.08M | 19.12M |
Change in cash | 27.59M | 21.62M | -1.37400M | 11.10M | 7.08M |
Begin period cash flow | 63.66M | 42.04M | 43.41M | 32.31M | 25.24M |
End period cash flow | 91.25M | 63.66M | 42.04M | 43.41M | 32.31M |
Total cash from operating activities | 62.53M | 61.58M | 38.84M | 31.42M | 24.66M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 0.83M | 0.81M | 0.80M | 0.84M | 6.08M |
Other cashflows from investing activities | -1.11100M | 0.65M | 0.18M | 0.17M | 0.24M |
Dividends paid | 26.11M | 18.79M | 13.55M | 10.92M | 9.84M |
Change to inventory | 0.02M | -0.04300M | 0.00100M | -0.00400M | 0.02M |
Change to account receivables | -13.47800M | -3.59100M | -9.53900M | 4.80M | -9.08900M |
Sale purchase of stock | -0.84500M | -4.01700M | -4.01700M | -0.84200M | -0.84200M |
Other cashflows from financing activities | -0.57400M | -0.50900M | -0.50100M | -0.55700M | 0.84M |
Change to netincome | -0.24000M | 0.40M | 2.07M | 3.63M | 1.19M |
Capital expenditures | 6.45M | 9.02M | 7.69M | 7.87M | 7.55M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -13.45600M | -3.63400M | -9.53800M | 4.79M | -8.96100M |
Stock based compensation | 1.23M | 0.03M | 0.68M | 0.65M | 0.78M |
Other non cash items | 1.05M | 16.32M | 7.19M | 7.50M | 5.34M |
Free cash flow | 56.09M | 52.55M | 31.15M | 23.55M | 17.11M |
Sector: Healthcare Industry: Health Information Services
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
PME Pro Medicus Ltd |
-4.79 1.71% | 276.03 | 301.96 | 166.67 | 158.93 | 133.17 | 159.43 | 209.48 |
CGS CogState Ltd |
-0.01 0.77% | 1.29 | 18.57 | 19.34 | 4.65 | 3.19 | 2.25 | 8.27 |
ONE Oneview Healthcare PLC |
- -% | 0.27 | - | - | 21.55 | 9.14 | 10.96 | -3.5247 |
ALC Alcidion Group Ltd |
0.001 1.08% | 0.09 | - | 3.05 | 3.50 | 1.46 | 3.33 | 53.70 |
SHG Singular Health Group Ltd |
-0.01 2.70% | 0.36 | - | - | 117.03 | 18.23 | 15.13 | -1.4686 |
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
450 Swan Street, Richmond, VIC, Australia, 3121
Name | Title | Year Born |
---|---|---|
Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Exec. Director | NA |
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Exec. Director | NA |
Mr. Clayton James Hatch CPA, B.Comm, CPA | CFO & Company Sec. | NA |
Dr. Malte Westerhoff | GM of Europe & Global CTO | NA |
Mr. Brad Levin | GM of North America & Global Head of Marketing | NA |
Mr. Sean Lambright | Global Head of Sales - Visage Imaging Inc | NA |
Ms. Teresa Gschwind | Global Head of Customer Service of Visage Imaging Inc. | NA |
Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Executive Director | NA |
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Executive Director | NA |
Mr. Clayton James Hatch B.Comm, CPA, CPA | Chief Financial Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.